{"id":9408,"date":"2024-01-23T07:16:25","date_gmt":"2024-01-23T07:16:25","guid":{"rendered":"https:\/\/dailyai.com\/?p=9408"},"modified":"2024-01-23T07:16:25","modified_gmt":"2024-01-23T07:16:25","slug":"fda-approves-dermasensors-ai-skin-cancer-detector","status":"publish","type":"post","link":"https:\/\/dailyai.com\/es\/2024\/01\/fda-approves-dermasensors-ai-skin-cancer-detector\/","title":{"rendered":"La FDA aprueba el detector de c\u00e1ncer de piel por IA de DermaSensor"},"content":{"rendered":"

La FDA ha aprobado la comercializaci\u00f3n en EE.UU. del detector port\u00e1til de c\u00e1ncer de piel con inteligencia artificial de DermaSensor.<\/strong><\/p>\n

El c\u00e1ncer de piel es el m\u00e1s frecuente en el mundo: uno de cada cinco estadounidenses lo padece a lo largo de su vida. La forma m\u00e1s grave de c\u00e1ncer de piel, el melanoma, mata a unos 9.000 estadounidenses cada a\u00f1o.<\/p>\n

Alrededor del 99% de los c\u00e1nceres de piel son curables, pero a menudo no se detectan hasta que es demasiado tarde. Los dermat\u00f3logos escasean y puede ser dif\u00edcil para un m\u00e9dico de atenci\u00f3n primaria (MAP) diferenciar entre un lunar benigno y un c\u00e1ncer de piel.<\/p>\n

DermaSensor ha dise\u00f1ado un dispositivo port\u00e1til no invasivo que puede detectar las tres formas m\u00e1s comunes de c\u00e1ncer de piel: melanoma, carcinoma basocelular y carcinoma escamoso.<\/p>\n

El dispositivo utiliza la espectroscopia de dispersi\u00f3n el\u00e1stica (ESS), una t\u00e9cnica de biopsia \u00f3ptica no invasiva. Cuando la punta del dispositivo se mantiene contra la lesi\u00f3n cut\u00e1nea sospechosa, emite pulsos de m\u00faltiples longitudes de onda de luz a trav\u00e9s de ella y captura los espectros resultantes.<\/p>\n

A continuaci\u00f3n, utiliza un algoritmo para analizar los espectros y determinar si la lesi\u00f3n es maligna o benigna.<\/p>\n

https:\/\/youtu.be\/yUaEgpMj8SY<\/p>\n

El algoritmo se entren\u00f3 con m\u00e1s de 20.000 exploraciones espectrales de m\u00e1s de 4.500 lesiones cut\u00e1neas utilizando una red neuronal directa y dos redes neuronales profundas. Una vez entrenado con las exploraciones espectrales etiquetadas, el dispositivo aprendi\u00f3 a decir si una nueva exploraci\u00f3n espectral era cancerosa y de qu\u00e9 tipo de c\u00e1ncer de piel se trataba.<\/p>\n

El dispositivo identifica positivamente el c\u00e1ncer de piel con una precisi\u00f3n de 96%, mientras que identifica correctamente lesiones benignas el 97% de las veces. Estas cifras son significativamente mejores que las alcanzadas por los PCP en sus ensayos.<\/p>\n

\"\"
Precisi\u00f3n de DermaSensor en la detecci\u00f3n de melanoma y c\u00e1ncer de piel no melanoma frente a m\u00e9dicos de atenci\u00f3n primaria humanos. Fuente: DermaSensor<\/figcaption><\/figure>\n

El dispositivo estar\u00e1 disponible mediante un modelo de suscripci\u00f3n a $199 al mes para cinco pacientes o $399 al mes para uso ilimitado.<\/p>\n

DermaSensor permitir\u00e1 a los m\u00e9dicos determinar r\u00e1pidamente si su paciente debe ser remitido a un dermat\u00f3logo. Tambi\u00e9n reducir\u00e1 las derivaciones innecesarias de pacientes a especialistas para descubrir que el m\u00e9dico, demasiado precavido, ha identificado err\u00f3neamente una lesi\u00f3n benigna.<\/p>\n

Este es uno de los varios detecci\u00f3n del c\u00e1ncer<\/a> y soluciones de tratamiento<\/a> que la IA ha hecho posible.<\/p>","protected":false},"excerpt":{"rendered":"

La FDA ha aprobado la comercializaci\u00f3n en Estados Unidos del detector port\u00e1til de c\u00e1ncer de piel con inteligencia artificial de DermaSensor. El c\u00e1ncer de piel es el m\u00e1s frecuente en el mundo: uno de cada cinco estadounidenses lo padece a lo largo de su vida. La forma m\u00e1s grave de c\u00e1ncer de piel, el melanoma, mata a unos 9.000 estadounidenses cada a\u00f1o. Alrededor del 99% de los c\u00e1nceres de piel son curables, pero a menudo no se detectan hasta que es demasiado tarde. Los dermat\u00f3logos escasean y puede resultar dif\u00edcil para un m\u00e9dico de atenci\u00f3n primaria (MAP) diferenciar entre un lunar benigno y un c\u00e1ncer de piel. DermaSensor ha dise\u00f1ado<\/p>","protected":false},"author":6,"featured_media":9423,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[83],"tags":[150,101],"class_list":["post-9408","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-product","tag-ai-benefits","tag-medtech"],"yoast_head":"\nFDA approves DermaSensor\u2019s AI skin cancer detector | DailyAI<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/dailyai.com\/es\/2024\/01\/fda-approves-dermasensors-ai-skin-cancer-detector\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FDA approves DermaSensor\u2019s AI skin cancer detector | DailyAI\" \/>\n<meta property=\"og:description\" content=\"The FDA has given its approval for DermaSensor\u2019s AI-powered handheld skin cancer detector to be sold in the US. Skin cancer is the most common cancer in the world with around one in five Americans developing skin cancer in their lifetime. The most serious form of skin cancer, melanoma, kills about 9,000 Americans each year. About 99% of skin cancers are curable, but they often go undetected until it\u2019s too late. Dermatologists are in short supply and it can be difficult for a primary care physician (PCP) to tell the difference between a benign mole and skin cancer. DermaSensor designed\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dailyai.com\/es\/2024\/01\/fda-approves-dermasensors-ai-skin-cancer-detector\/\" \/>\n<meta property=\"og:site_name\" content=\"DailyAI\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-23T07:16:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/dailyai.com\/wp-content\/uploads\/2024\/01\/skin-cancer-examination.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"667\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Eugene van der Watt\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@DailyAIOfficial\" \/>\n<meta name=\"twitter:site\" content=\"@DailyAIOfficial\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Eugene van der Watt\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/fda-approves-dermasensors-ai-skin-cancer-detector\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/fda-approves-dermasensors-ai-skin-cancer-detector\\\/\"},\"author\":{\"name\":\"Eugene van der Watt\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/person\\\/7ce525c6d0c79838b7cc7cde96993cfa\"},\"headline\":\"FDA approves DermaSensor\u2019s AI skin cancer detector\",\"datePublished\":\"2024-01-23T07:16:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/fda-approves-dermasensors-ai-skin-cancer-detector\\\/\"},\"wordCount\":369,\"publisher\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/fda-approves-dermasensors-ai-skin-cancer-detector\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/skin-cancer-examination.jpg\",\"keywords\":[\"AI benefits\",\"MedTech\"],\"articleSection\":[\"Product\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/fda-approves-dermasensors-ai-skin-cancer-detector\\\/\",\"url\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/fda-approves-dermasensors-ai-skin-cancer-detector\\\/\",\"name\":\"FDA approves DermaSensor\u2019s AI skin cancer detector | DailyAI\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/fda-approves-dermasensors-ai-skin-cancer-detector\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/fda-approves-dermasensors-ai-skin-cancer-detector\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/skin-cancer-examination.jpg\",\"datePublished\":\"2024-01-23T07:16:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/fda-approves-dermasensors-ai-skin-cancer-detector\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/fda-approves-dermasensors-ai-skin-cancer-detector\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/fda-approves-dermasensors-ai-skin-cancer-detector\\\/#primaryimage\",\"url\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/skin-cancer-examination.jpg\",\"contentUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2024\\\/01\\\/skin-cancer-examination.jpg\",\"width\":1000,\"height\":667},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/2024\\\/01\\\/fda-approves-dermasensors-ai-skin-cancer-detector\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/dailyai.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FDA approves DermaSensor\u2019s AI skin cancer detector\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#website\",\"url\":\"https:\\\/\\\/dailyai.com\\\/\",\"name\":\"DailyAI\",\"description\":\"Your Daily Dose of AI News\",\"publisher\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dailyai.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#organization\",\"name\":\"DailyAI\",\"url\":\"https:\\\/\\\/dailyai.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Daily-Ai_TL_colour.png\",\"contentUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/06\\\/Daily-Ai_TL_colour.png\",\"width\":4501,\"height\":934,\"caption\":\"DailyAI\"},\"image\":{\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/DailyAIOfficial\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/dailyaiofficial\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@DailyAIOfficial\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/#\\\/schema\\\/person\\\/7ce525c6d0c79838b7cc7cde96993cfa\",\"name\":\"Eugene van der Watt\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Eugine_Profile_Picture-96x96.png\",\"url\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Eugine_Profile_Picture-96x96.png\",\"contentUrl\":\"https:\\\/\\\/dailyai.com\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Eugine_Profile_Picture-96x96.png\",\"caption\":\"Eugene van der Watt\"},\"description\":\"Eugene comes from an electronic engineering background and loves all things tech. When he takes a break from consuming AI news you'll find him at the snooker table.\",\"sameAs\":[\"www.linkedin.com\\\/in\\\/eugene-van-der-watt-16828119\"],\"url\":\"https:\\\/\\\/dailyai.com\\\/es\\\/author\\\/eugene\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La FDA aprueba el detector de c\u00e1ncer de piel por IA de DermaSensor | DailyAI","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/dailyai.com\/es\/2024\/01\/fda-approves-dermasensors-ai-skin-cancer-detector\/","og_locale":"es_ES","og_type":"article","og_title":"FDA approves DermaSensor\u2019s AI skin cancer detector | DailyAI","og_description":"The FDA has given its approval for DermaSensor\u2019s AI-powered handheld skin cancer detector to be sold in the US. Skin cancer is the most common cancer in the world with around one in five Americans developing skin cancer in their lifetime. The most serious form of skin cancer, melanoma, kills about 9,000 Americans each year. About 99% of skin cancers are curable, but they often go undetected until it\u2019s too late. Dermatologists are in short supply and it can be difficult for a primary care physician (PCP) to tell the difference between a benign mole and skin cancer. DermaSensor designed","og_url":"https:\/\/dailyai.com\/es\/2024\/01\/fda-approves-dermasensors-ai-skin-cancer-detector\/","og_site_name":"DailyAI","article_published_time":"2024-01-23T07:16:25+00:00","og_image":[{"width":1000,"height":667,"url":"https:\/\/dailyai.com\/wp-content\/uploads\/2024\/01\/skin-cancer-examination.jpg","type":"image\/jpeg"}],"author":"Eugene van der Watt","twitter_card":"summary_large_image","twitter_creator":"@DailyAIOfficial","twitter_site":"@DailyAIOfficial","twitter_misc":{"Escrito por":"Eugene van der Watt","Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/dailyai.com\/2024\/01\/fda-approves-dermasensors-ai-skin-cancer-detector\/#article","isPartOf":{"@id":"https:\/\/dailyai.com\/2024\/01\/fda-approves-dermasensors-ai-skin-cancer-detector\/"},"author":{"name":"Eugene van der Watt","@id":"https:\/\/dailyai.com\/#\/schema\/person\/7ce525c6d0c79838b7cc7cde96993cfa"},"headline":"FDA approves DermaSensor\u2019s AI skin cancer detector","datePublished":"2024-01-23T07:16:25+00:00","mainEntityOfPage":{"@id":"https:\/\/dailyai.com\/2024\/01\/fda-approves-dermasensors-ai-skin-cancer-detector\/"},"wordCount":369,"publisher":{"@id":"https:\/\/dailyai.com\/#organization"},"image":{"@id":"https:\/\/dailyai.com\/2024\/01\/fda-approves-dermasensors-ai-skin-cancer-detector\/#primaryimage"},"thumbnailUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2024\/01\/skin-cancer-examination.jpg","keywords":["AI benefits","MedTech"],"articleSection":["Product"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/dailyai.com\/2024\/01\/fda-approves-dermasensors-ai-skin-cancer-detector\/","url":"https:\/\/dailyai.com\/2024\/01\/fda-approves-dermasensors-ai-skin-cancer-detector\/","name":"La FDA aprueba el detector de c\u00e1ncer de piel por IA de DermaSensor | DailyAI","isPartOf":{"@id":"https:\/\/dailyai.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/dailyai.com\/2024\/01\/fda-approves-dermasensors-ai-skin-cancer-detector\/#primaryimage"},"image":{"@id":"https:\/\/dailyai.com\/2024\/01\/fda-approves-dermasensors-ai-skin-cancer-detector\/#primaryimage"},"thumbnailUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2024\/01\/skin-cancer-examination.jpg","datePublished":"2024-01-23T07:16:25+00:00","breadcrumb":{"@id":"https:\/\/dailyai.com\/2024\/01\/fda-approves-dermasensors-ai-skin-cancer-detector\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dailyai.com\/2024\/01\/fda-approves-dermasensors-ai-skin-cancer-detector\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/dailyai.com\/2024\/01\/fda-approves-dermasensors-ai-skin-cancer-detector\/#primaryimage","url":"https:\/\/dailyai.com\/wp-content\/uploads\/2024\/01\/skin-cancer-examination.jpg","contentUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2024\/01\/skin-cancer-examination.jpg","width":1000,"height":667},{"@type":"BreadcrumbList","@id":"https:\/\/dailyai.com\/2024\/01\/fda-approves-dermasensors-ai-skin-cancer-detector\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dailyai.com\/"},{"@type":"ListItem","position":2,"name":"FDA approves DermaSensor\u2019s AI skin cancer detector"}]},{"@type":"WebSite","@id":"https:\/\/dailyai.com\/#website","url":"https:\/\/dailyai.com\/","name":"DailyAI","description":"Su dosis diaria de noticias sobre IA","publisher":{"@id":"https:\/\/dailyai.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dailyai.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/dailyai.com\/#organization","name":"DailyAI","url":"https:\/\/dailyai.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/dailyai.com\/#\/schema\/logo\/image\/","url":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/06\/Daily-Ai_TL_colour.png","contentUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/06\/Daily-Ai_TL_colour.png","width":4501,"height":934,"caption":"DailyAI"},"image":{"@id":"https:\/\/dailyai.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/DailyAIOfficial","https:\/\/www.linkedin.com\/company\/dailyaiofficial\/","https:\/\/www.youtube.com\/@DailyAIOfficial"]},{"@type":"Person","@id":"https:\/\/dailyai.com\/#\/schema\/person\/7ce525c6d0c79838b7cc7cde96993cfa","name":"Eugene van der Watt","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/Eugine_Profile_Picture-96x96.png","url":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/Eugine_Profile_Picture-96x96.png","contentUrl":"https:\/\/dailyai.com\/wp-content\/uploads\/2023\/07\/Eugine_Profile_Picture-96x96.png","caption":"Eugene van der Watt"},"description":"Eugene es ingeniero electr\u00f3nico y le encanta todo lo relacionado con la tecnolog\u00eda. Cuando descansa de consumir noticias sobre IA, lo encontrar\u00e1 jugando al billar.","sameAs":["www.linkedin.com\/in\/eugene-van-der-watt-16828119"],"url":"https:\/\/dailyai.com\/es\/author\/eugene\/"}]}},"_links":{"self":[{"href":"https:\/\/dailyai.com\/es\/wp-json\/wp\/v2\/posts\/9408","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailyai.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailyai.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailyai.com\/es\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/dailyai.com\/es\/wp-json\/wp\/v2\/comments?post=9408"}],"version-history":[{"count":3,"href":"https:\/\/dailyai.com\/es\/wp-json\/wp\/v2\/posts\/9408\/revisions"}],"predecessor-version":[{"id":9426,"href":"https:\/\/dailyai.com\/es\/wp-json\/wp\/v2\/posts\/9408\/revisions\/9426"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailyai.com\/es\/wp-json\/wp\/v2\/media\/9423"}],"wp:attachment":[{"href":"https:\/\/dailyai.com\/es\/wp-json\/wp\/v2\/media?parent=9408"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailyai.com\/es\/wp-json\/wp\/v2\/categories?post=9408"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailyai.com\/es\/wp-json\/wp\/v2\/tags?post=9408"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}